Edition:
United States

Abeona Therapeutics Inc (ABEO.OQ)

ABEO.OQ on NASDAQ Stock Exchange Capital Market

16.10USD
14 Dec 2017
Change (% chg)

-- (--)
Prev Close
$16.10
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
238,102
52-wk High
$22.70
52-wk Low
$4.05

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.22 -0.132
Jun '17 0.22 -0.206
Mar '17 0.19 -0.130
FY 2016 Dec '16 0.26 -0.185
Sep '16 0.18 -0.079
Jun '16 0.21 -0.204
Mar '16 0.23 -0.169
FY 2015 Dec '15 0.22 -0.071
Sep '15 0.28 -0.191
Jun '15 0.28 -0.160
Mar '15 0.26 -0.100
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 7 0.24 0.31 0.20 1.69
Quarter Ending Mar-18 5 0.26 0.40 0.19 --
Year Ending Dec-17 7 0.87 1.00 0.80 2.98
Year Ending Dec-18 7 1.06 1.72 0.80 37.44
Earnings (per share)
Quarter Ending Dec-17 8 -0.14 -0.11 -0.19 -0.15
Quarter Ending Mar-18 5 -0.15 -0.12 -0.17 -0.24
Year Ending Dec-17 8 -0.61 -0.58 -0.66 -0.56
Year Ending Dec-18 8 -0.64 -0.40 -0.76 -0.03
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 190.77 35.50
P/E High - Last 5 Yrs. 4.11 277.36 45.22
P/E Low - Last 5 Yrs. 4.11 92.80 24.21
Beta 2.22 0.82 0.91
Price to Sales (TTM) 857.72 117.72 5.89
Price to Book (MRQ) 7.33 21.83 5.66
Price to Tangible Book (MRQ) 14.12 25.81 7.25
Price to Cash Flow (TTM) -- 103.69 24.38
% Owned Institutions 42.13 5.72 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 2.00 5.25
Payout Ratio(TTM) -- 98.06 46.15

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 19.02 -3.06 6.81
Sales (TTM) vs TTM 1 Yr. Ago 3.54 30.14 5.59
Sales - 5 Yr. Growth Rate -13.53 33.20 10.23
EPS (MRQ) vs Qtr. 1 Yr. Ago -67.79 -148.11 7.98
EPS (TTM) vs TTM 1 Yr. Ago -24.60 -- --
EPS - 5 Yr. Growth Rate -- 43.94 10.93
Capital Spending - 5 Yr. Growth Rate 66.96 41.00 15.14

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.55
Current Ratio (MRQ) 22.13 5.70 3.57
LT Debt to Equity (MRQ) 0.00 14.63 13.37
Total Debt to Equity (MRQ) 0.00 17.10 19.35
Interest Coverage (TTM) -- -135.87 44.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 44.20 54.91
Gross Margin - 5 Yr. Avg. -- 55.70 52.46
EBITD Margin (TTM) -2,742.03 -- --
EBITD - 5 Yr. Avg -557.73 -219.33 15.51
Operating Margin (TTM) -2,838.04 -637.28 6.68
Operating Margin - 5 Yr. Avg. -577.18 -236.27 10.99
Pre-Tax Margin (TTM) -2,946.58 -607.21 7.52
Pre-Tax Margin - 5 Yr. Avg. -744.73 -236.41 11.40
Net Profit Margin (TTM) -2,946.58 -604.71 3.74
Net Profit Margin - 5 Yr. Avg. -744.73 -239.71 7.69
Effective Tax Rate (TTM) -- 15.46 24.27
Effective Tax Rate - 5 Yr. Avg. -- 19.04 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) 46,211 21,870,754 851,754,569
Net Income/Employee (TTM) -1,361,632 -1,731,043 99,535,212
Receivable Turnover (TTM) 2.45 26.18 6.13
Inventory Turnover (TTM) -- 2.65 3.55
Asset Turnover (TTM) 0.01 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -30.52 -9.33 11.32
Return on Assets - 5 Yr. Avg. -44.28 0.11 12.28
Return on Investment (TTM) -32.26 -11.61 14.44
Return on Investment - 5 Yr. Avg. -54.88 3.32 16.08
Return on Equity (TTM) -33.74 -35.87 16.05
Return on Equity - 5 Yr. Avg. -94.60 5.69 17.28
  1 Year 3 Year 5 Year
Sales % -14.52 -24.21 -13.53
EPS (TTM) % -21.58 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Abeona Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 46.64%
# of Holders: 116
Total Shares Held: 21,815,279
3 Mo. Net Change: 6,314,926
# New Positions: 31
# Closed Positions: 14
# Increased Positions: 67
# Reduced Positions: 37
# Net Buyers: 30
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.